Sector
PharmaceuticalsOpen
₹4.7Prev. Close
₹4.85Turnover(Lac.)
₹0.08Day's High
₹4.7Day's Low
₹4.6552 Week's High
₹052 Week's Low
₹0Book Value
₹-27.45Face Value
₹10Mkt Cap (₹ Cr.)
31.68P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Jun-2015 | Mar-2014 | Mar-2013 | Mar-2012 |
|---|---|---|---|---|
Equity Capital | 68.13 | 68.13 | 64.39 | 48.23 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -110.41 | 211.34 | 129.87 | 94.86 |
Net Worth | -42.28 | 279.47 | 194.26 | 143.09 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Jun-2015 | Mar-2014 | Mar-2013 | Mar-2012 |
|---|---|---|---|---|
Revenue | 787.06 | 911.1 | 664.26 | 436.62 |
yoy growth (%) | -13.61 | 37.16 | 52.13 | 20.43 |
Raw materials | -790.06 | -683.61 | -497.08 | -347.14 |
As % of sales | 100.38 | 75.03 | 74.83 | 79.5 |
Employee costs | -15.98 | -17.41 | -13.44 | -9.08 |
| Y/e 31 Mar( In .Cr) | Jun-2015 | Mar-2014 | Mar-2013 | Mar-2012 |
|---|---|---|---|---|
Profit before tax | -137.82 | 86.39 | 62.55 | 37.21 |
Depreciation | -29.46 | -13.9 | -12.58 | -3.23 |
Tax paid | 5.23 | -27.49 | -21.93 | -17.8 |
Working capital | -54.91 | 173.49 | 115.59 | 47.78 |
Other operating items |
| Y/e 31 Mar | Jun-2015 | Mar-2014 | Mar-2013 | Mar-2012 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -13.61 | 37.16 | 52.13 | 20.43 |
Op profit growth | -124.38 | 32.3 | 97.29 | 64.34 |
EBIT growth | -140.82 | 34.3 | 87.47 | 65.81 |
Net profit growth | -643.37 | 45 | 109.25 | 14.83 |
| Particulars (Rupees in Crores.) | Mar-2014 | Mar-2013 | Mar-2012 |
|---|---|---|---|
Gross Sales | 961.28 | 704.35 | 467.07 |
Excise Duty | 0 | 0 | 0 |
Net Sales | 961.28 | 704.35 | 467.07 |
Other Operating Income | 1.39 | 1.75 | 0.64 |
Other Income | 0.54 | 0.77 | 0.57 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director & CEO
B Arvind Shah
Whole-time Director
Chandra Ravindran
Company Secretary
P R Krishnan
Director
Madhav Yadav
Additional Director
Timothy Allen
Additional Director
M Vasudevan
190 Poonamallee High Road,
Tamil Nadu - 600084
Tel: 91-44-43439595
Website: http://www.arvindremedies.com
Email: [email protected]
Subramanian Building,
1ST Floor No 1, Club House Road,
Chennai - 600002
Tel: 91-44-28462700
Website: www.cameoindia.com
Email: [email protected]
Summary
Promoted by Arvind Kumar Shah, C M K Reddy, Chhotalal and Chandra Ravindran Arvind Remedies (ARL) was incorporated in Jun.88 as a private limited company which was later converted into a public limite...
Read More
Reports by Arvind Remedies Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.